NexgenRX Inc. (NXG) — Cash Flow Quality Index
NexgenRX Inc. (NXG) has a Cash Flow Quality Index of 1.49x as of September 2025. Operating cash flow of CA$880.82K exceeds net income of CA$589.78K, indicating high earnings quality where cash backs reported profits. Explore NexgenRX Inc. cash conversion from operations to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
NexgenRX Inc. Cash Flow Quality Index (2013–2024)
Historical Cash Flow Quality Index for NexgenRX Inc. across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check total reinvestment intensity of NexgenRX Inc. to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for NexgenRX Inc. (2013–2024)
Year-by-year earnings quality comparison for NexgenRX Inc.. For live market cap and the full company financial profile, see NXG market cap.
| Year | Quality Index | Operating CF (CAD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.87x | CA$1.15 Million | CA$614.57K | ▲ +96.6% |
| 2021 | 0.95x | CA$3.82 Million | CA$4.02 Million | ▼ -24.1% |
| 2020 | 1.25x | CA$2.65 Million | CA$2.12 Million | ▲ +50.1% |
| 2016 | 0.84x | CA$490.96K | CA$587.80K | ▼ -34.3% |
| 2013 | 1.27x | CA$774.08K | CA$608.55K | — |